Article

A Mouse Model of the Protease Activated Receptor 4 (PAR4) Pro310Leu Variant has Reduced…

medRxiv · 2023 · Han, X.; Knauss, E. A.; de la Fuente, M.; Li, W.; Conlon, R. A.; LePage, D. F.; Jiang, W.; Renna, S. A.; McKenzie, S. E.; Nieman, M. T.

Key facts

Title A Mouse Model of the Protease Activated Receptor 4 (PAR4) Pro310Leu Variant has Reduced Platelet Reactivity
First author Han, X.; Knauss, E. A.; de la Fuente, M.; Li, W.; Conlon, R. A.; LePage, D. F.; Jiang, W.; Renna, S. A.; McKenzie, S. E.; Nieman, M. T.
Journal medRxiv
Published Jan 1, 2023
DOI 10.1101/2023.12.01.569075
Devices mentioned K760159, K771198, K922800
Product codes mentioned CEK, GHR, JBX, JBY

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature